Diabetes & Metabolism

Papers
(The H4-Index of Diabetes & Metabolism is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Contents - page 186
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial70
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study67
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France60
Editorial board49
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department44
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report37
Contents36
Editorial board35
Association between adipose deposition and mortality among adults without major cardiovascular risk factors35
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood33
Body weight trends in Individuals with type 1 diabetes using automated insulin delivery vs. traditional insulin pumps32
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients31
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes31
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”31
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis30
Concise review of lipidomics in nonalcoholic fatty liver disease30
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–202129
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review27
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes27
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–202026
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes26
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes26
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study25
Sommaire25
Contents25
Type B insulin resistance syndrome: A case report25
0.029067039489746